{"id":329072,"date":"2021-05-06T14:00:00","date_gmt":"2021-05-06T12:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/proven-minimally-invasive-therapy-option-for-children\/"},"modified":"2021-05-06T14:00:00","modified_gmt":"2021-05-06T12:00:00","slug":"proven-minimally-invasive-therapy-option-for-children","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/proven-minimally-invasive-therapy-option-for-children\/","title":{"rendered":"Proven minimally invasive therapy option for children"},"content":{"rendered":"<p><strong>Vesicoureteral reflux affects approximately 1% of newborns. A gel composed of dextranomer and hyaluronic acid is a proven minimally invasive treatment option with proven efficacy. The therapy stops the reflux of urine into the ureter very effectively. In studies, treatment proved successful in over 90% of children with VUR grade 2-4.<\/strong><\/p>\n<p> <!--more--> <\/p>\n<p>Deflux\u00ae is a minimally invasive treatment used in children with vesicoureteral reflux (VUR) and has been a proven therapy in children with VUR for more than 20 years with over 400,000 procedures [1]. The company Farco-Pharma GmbH has announced that they are taking over the distribution rights for Deflux\u00ae for the treatment of children with VUR in Germany, Austria and Switzerland. With the acquisition of the distribution rights, Farco-Pharma further expands its urology portfolio of high-quality gels and instillation solutions [1].<\/p>\n<h2 id=\"\">&nbsp;<\/h2>\n<table border=\"1\" cellpadding=\"5\" cellspacing=\"1\" style=\"width:500px\">\n<tbody>\n<tr>\n<td>\n<p><strong>Effective and tolerable therapy<\/strong><\/p>\n<p>Deflux\u00ae is a viscous injectable gel of dextranomer in a carrier gel that is injected at the site where the ureter connects to the bladder in children with VUR using a minimally invasive procedure. It&nbsp;is an effective and tolerable therapy for VUR that prevents urine reflux into the kidneys&nbsp;[2]. Connective tissue cells gradually grow into the gel injected at the junction of the ureter and bladder, and new tissue is formed. Deflux\u00ae consists of dextranomer and hyaluronic acid. The gel is available in glass syringes with Luer lock connector and 1&nbsp;ml content.<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 id=\"-2\">&nbsp;<\/h2>\n<h2 id=\"high-success-rate\">High success rate<\/h2>\n<p>Vesicoureteral reflux (VUR), a urinary tract disorder divided into five degrees of severity ( <span style=\"font-family:franklin gothic demi\">Overview 1)<\/span>, affects approximately 1% of newborns. Usually, the valve mechanism of the ureteral orifice prevents urine from flowing back into the ureter and kidney. In VUR patients, this mechanism is disturbed. The refluxing urine may contain bacteria, leading to urinary tract infections (UTIs) or febrile urinary tract infections (fHWIs). Kidney infections and kidney damage can result. Therapy with Deflux\u00ae effectively stops the reflux of urine into the ureter. In studies, treatment proved successful in up to 93% of children with a VUR grade of 2-4 [2].<\/p>\n<h2 id=\"-3\">&nbsp;<\/h2>\n<h2 id=\"-4\"><img fetchpriority=\"high\" decoding=\"async\" class=\" size-full wp-image-16103\" alt=\"\" src=\"https:\/\/medizinonline.com\/wp-content\/uploads\/2021\/05\/ubersicht1_hp4_s25.png\" style=\"height:408px; width:400px\" width=\"764\" height=\"779\"><\/h2>\n<h2 id=\"-5\">&nbsp;<\/h2>\n<h2 id=\"advantageous-safety-profile\">Advantageous safety profile<\/h2>\n<p>The use of Deflux\u00ae in children with VUR is minimally invasive. Using a cystoscope, the doctor injects the gel at the point where the ureter joins the bladder (also possible as a unilateral treatment). The injection stops the backflow of urine into the ureter and kidneys. Connective tissue cells subsequently infiltrate the injected gel and form new collagen tissue. In total, the procedure, which can be performed under general anesthesia, takes 15&nbsp;minutes. The children can usually go about their usual activities the following day. The safety of Deflux\u00ae is contributed by microspheres made of dextranomer, which prevent migration of the gel due to their large format (80-250&nbsp;\u03bcm) [3]. The hyaluronic acid contained is of non-animal origin and designed for optimal biocompatibility. The active ingredient has already been used in more than 40 million treatments worldwide [1].<\/p>\n<p><em>Source: ARCO-Pharma<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>Literature:<\/p>\n<ol>\n<li>&#8220;Established therapy option complements urology specialist&#8217;s portfolio,&#8221; Farco-Pharma, Cologne, Feb. 17, 2021.<\/li>\n<li>Kalisvaart JF: Intermediate to long-term follow-up indicated low risk of recurrence after double hit endoscopic treatment for primary vesicoureteral reflux. J Ped Urol 2012; 8(4): 359-365.<\/li>\n<li>Deflux for the treatment of children with vesicoureteral reflux (VUR): Product monograph. Q-Med, AB. Uppsala, Sweden. 2005.<\/li>\n<li>Uni T\u00fcbingen: Vesicoureteral Reflux, www.medizin.uni-tuebingen.de (last accessed 03\/16\/2021).<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p><em>HAUSARZT PRAXIS 2021; 16(4): 25<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vesicoureteral reflux affects approximately 1% of newborns. A gel composed of dextranomer and hyaluronic acid is a proven minimally invasive treatment option with proven efficacy. The therapy stops the reflux&hellip;<\/p>\n","protected":false},"author":7,"featured_media":106075,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Vesicoureteral reflux (VUR)","footnotes":""},"category":[11297,11530,11437,11548,11490],"tags":[20536,20538],"powerkit_post_featured":[],"class_list":["post-329072","post","type-post","status-publish","format-standard","has-post-thumbnail","category-general-internal-medicine","category-market-medicine","category-pediatrics","category-rx-en","category-urology","tag-deflux-en","tag-vur-en","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-01 00:22:06","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":329090,"slug":"option-therapeutique-mini-invasive-eprouvee-pour-les-enfants","post_title":"Option th\u00e9rapeutique mini-invasive \u00e9prouv\u00e9e pour les enfants","href":"https:\/\/medizinonline.com\/fr\/option-therapeutique-mini-invasive-eprouvee-pour-les-enfants\/"},"it_IT":{"locale":"it_IT","id":329106,"slug":"una-comprovata-opzione-di-terapia-minimamente-invasiva-per-i-bambini","post_title":"Una comprovata opzione di terapia minimamente invasiva per i bambini","href":"https:\/\/medizinonline.com\/it\/una-comprovata-opzione-di-terapia-minimamente-invasiva-per-i-bambini\/"},"pt_PT":{"locale":"pt_PT","id":329118,"slug":"opcao-de-terapia-minimamente-invasiva-comprovada-para-criancas","post_title":"Op\u00e7\u00e3o de terapia minimamente invasiva comprovada para crian\u00e7as","href":"https:\/\/medizinonline.com\/pt-pt\/opcao-de-terapia-minimamente-invasiva-comprovada-para-criancas\/"},"es_ES":{"locale":"es_ES","id":329121,"slug":"opcion-terapeutica-minimamente-invasiva-de-eficacia-probada-para-los-ninos","post_title":"Opci\u00f3n terap\u00e9utica m\u00ednimamente invasiva de eficacia probada para los ni\u00f1os","href":"https:\/\/medizinonline.com\/es\/opcion-terapeutica-minimamente-invasiva-de-eficacia-probada-para-los-ninos\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/329072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=329072"}],"version-history":[{"count":0,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/329072\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/106075"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=329072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=329072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=329072"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=329072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}